The role of aberrant proteolysis in lymphomagenesis
- PMID: 26049759
- PMCID: PMC4459522
- DOI: 10.1097/MOH.0000000000000156
The role of aberrant proteolysis in lymphomagenesis
Abstract
Purpose of review: Deregulated proteolysis is increasingly being implicated in pathogenesis of lymphoma. In this review, we highlight the major cellular processes that are affected by deregulated proteolysis of critical substrates that promote lymphoproliferative disorders.
Recent findings: Emerging evidence supports the role of aberrant proteolysis by the ubiquitin proteasome system (UPS) in lymphoproliferative disorders. Several UPS mediators are identified to be altered in lymphomagenesis. However, the precise role of their alteration and comprehensive knowledge of their target substrate critical for lymphomagenesis is far from complete.
Summary: Many E3 ligase and deubiquitinases that contribute to regulated proteolysis of substrates critical for major cellular processes are altered in various lineages of lymphoma. Understanding of the proteolytic regulatory mechanisms of these major cellular pathways may offer novel biomarkers and targets for lymphoma therapy.
Conflict of interest statement
There are no conflicts of interest to declare.
Figures
Similar articles
-
Regulation of Epithelial-Mesenchymal Transition by E3 Ubiquitin Ligases and Deubiquitinase in Cancer.Curr Cancer Drug Targets. 2016;16(2):110-8. doi: 10.2174/1568009616666151112122126. Curr Cancer Drug Targets. 2016. PMID: 26560121 Review.
-
Ubiquitination: Friend and foe in cancer.Int J Biochem Cell Biol. 2018 Aug;101:80-93. doi: 10.1016/j.biocel.2018.06.001. Epub 2018 Jun 1. Int J Biochem Cell Biol. 2018. PMID: 29864543 Review.
-
Role of the ubiquitin proteasome system in hematologic malignancies.Immunol Rev. 2015 Jan;263(1):224-39. doi: 10.1111/imr.12236. Immunol Rev. 2015. PMID: 25510280 Review.
-
Ubiquitin recognition by the proteasome.J Biochem. 2017 Feb 1;161(2):113-124. doi: 10.1093/jb/mvw091. J Biochem. 2017. PMID: 28069863 Review.
-
Dysregulation of ubiquitin ligases in cancer.Drug Resist Updat. 2015 Nov;23:1-11. doi: 10.1016/j.drup.2015.09.001. Epub 2015 Sep 28. Drug Resist Updat. 2015. PMID: 26690337 Free PMC article. Review.
Cited by
-
LBD: a manually curated database of experimentally validated lymphoma biomarkers.Database (Oxford). 2022 Jul 5;2022:baac051. doi: 10.1093/database/baac051. Database (Oxford). 2022. PMID: 35788654 Free PMC article.
-
Loss of Setd4 delays radiation-induced thymic lymphoma in mice.DNA Repair (Amst). 2020 Feb;86:102754. doi: 10.1016/j.dnarep.2019.102754. Epub 2019 Nov 25. DNA Repair (Amst). 2020. PMID: 31794893 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials